Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20013030HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TVIS20021026HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TVIS20021887HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TVIS20021889HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TVIS20021888HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TVIS20021025HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TVIS20021021HPVENSG00000119508.18protein_codingNR4A3YesNo8013Q92570
TCGA Plot Options
Drug Information
GeneNR4A3
DrugBank IDDB01254
Drug NameDasatinib
Target IDBE0008998
UniProt IDQ92570
Regulation Typeinhibitor
PubMed IDs17684099
CitationsHantschel O, Rix U, Schmidt U, Burckstummer T, Kneidinger M, Schutze G, Colinge J, Bennett KL, Ellmeier W, Valent P, Superti-Furga G: The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13283-8. Epub 2007 Aug 7.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
PathwaysDasatinib Inhibition of BCR-ABL
PharmGKBPA162372878
ChEMBLCHEMBL1421